Dn B Asset Management As Celldex Therapeutics, Inc. Transaction History
Dn B Asset Management As
- $19.9 Billion
- Q2 2024
A detailed history of Dn B Asset Management As transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Dn B Asset Management As holds 7,872 shares of CLDX stock, worth $342,195. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,872
Previous 5,349
47.17%
Holding current value
$342,195
Previous $224,000
29.91%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CLDX
# of Institutions
195Shares Held
63.4MCall Options Held
206KPut Options Held
176K-
Wellington Management Group LLP Boston, MA8.08MShares$351 Million0.05% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$204 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.74MShares$163 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.39MShares$147 Million9.76% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.33MShares$145 Million2.17% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $2.03B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...